MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1784.68%
Quick Ratio
1784.68%
Cash Ratio
219.22%
Debt to Asset Ratio
34.11%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
291,337
423,308
347,559
286,497
Marketable securities
2,073,015
2,018,477
1,628,269
1,629,213
Accounts receivable
-
-
0
0
Prepaid expenses and other current assets
7,418
6,577
9,843
13,382
Total current assets
2,371,770
2,448,362
1,985,671
1,929,092
Total property and equipment, gross
207,661
207,517
206,903
206,444
Accumulated depreciation
99,593
95,342
91,052
85,613
Property and equipment, net
108,068
112,175
115,851
120,831
Marketable securities, non-current
-
-
-
28,412
Restricted cash
7,629
7,629
7,629
8,006
Operating lease assets
125,592
128,671
131,724
134,659
Other non-current assets
37,711
28,983
24,368
24,308
Total assets
2,650,770
2,725,820
2,265,243
2,245,308
Accounts payable
11,307
13,647
11,138
11,798
Accrued expenses
70,278
74,932
89,407
84,182
Deferred revenue, current
15,189
15,344
15,771
1,295
Accrued tax liabilities
494
638
1,113
3,426
Operating lease liabilities
18,646
18,612
18,578
18,256
Other current liabilities
16,982
13,113
13,113
0
Total current liabilities
132,896
136,286
149,120
118,957
Deferred revenue, non-current
-
-
0
12,323
Long-term debt
586,198
585,470
-
-
Operating lease liabilities, net of current portion
178,904
183,560
188,168
192,768
Other non-current liabilities
6,221
5,948
6,142
5,278
Total liabilities
904,219
911,264
343,430
329,326
Common shares, chf 0.03 nominal value, 144,447,967 and 132,477,166 shares authorized at june 30, 2026 and december 31, 2025, respectively, 96,761,275 and 96,009,657 shares issued at june 30, 2026 and december 31, 2025, respectively, 96,660,959 and 95,894,341 shares outstanding at june 30, 2026 and december 31, 2025, respectively
3,130
3,115
3,087
3,013
Treasury shares, at cost, 100,316 and 115,316 shares at june 30, 2026 and december 31, 2025, respectively
60
60
60
60
Additional paid-in capital
3,909,746
3,883,924
3,861,516
3,724,981
Accumulated deficit
-2,161,636
-2,070,482
-1,947,551
-1,816,938
Accumulated other comprehensive (loss) income
-4,629
-1,941
4,821
4,986
Total shareholders' equity
1,746,551
1,814,556
1,921,813
1,915,982
Total liabilities and shareholders equity
2,650,770
2,725,820
2,265,243
2,245,308
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$2,073,015K (35.70%↑ Y/Y)Cash and cashequivalents$291,337K (50.47%↑ Y/Y)Prepaid expenses andother current assets$7,418K (-40.32%↓ Y/Y)Total property andequipment, gross$207,661K (0.55%↑ Y/Y)Total current assets$2,371,770K (36.81%↑ Y/Y)Operating lease assets$125,592K (-8.75%↓ Y/Y)Property and equipment,net$108,068K (-13.49%↓ Y/Y)Other non-currentassets$37,711K (48.05%↑ Y/Y)Restricted cash$7,629K (-4.71%↓ Y/Y)Accumulated depreciation$99,593K (22.05%↑ Y/Y)Total assets$2,650,770K (30.60%↑ Y/Y)Total liabilities andshareholders equity$2,650,770K (30.60%↑ Y/Y)Total shareholders'equity$1,746,551K (2.07%↑ Y/Y)Total liabilities$904,219K (183.82%↑ Y/Y)Accumulated deficit-$2,161,636K (-26.37%↓ Y/Y)Accumulated othercomprehensive (loss) income-$4,629K (-214.55%↓ Y/Y)Treasury shares, at cost,100,316 and 115,316...$60K (-3.23%↓ Y/Y)Additional paid-in capital$3,909,746K (14.49%↑ Y/Y)Long-term debt$586,198K Operating leaseliabilities, net of current...$178,904K (-9.38%↓ Y/Y)Total currentliabilities$132,896K (27.34%↑ Y/Y)Other non-currentliabilities$6,221K (38.99%↑ Y/Y)Common shares, chf 0.03nominal value,...$3,130K (12.03%↑ Y/Y)Accrued expenses$70,278K (-4.69%↓ Y/Y)Operating leaseliabilities$18,646K (3.43%↑ Y/Y)Other currentliabilities$16,982K Deferred revenue,current$15,189K (613.43%↑ Y/Y)Accounts payable$11,307K (15.93%↑ Y/Y)Accrued tax liabilities$494K (-30.91%↓ Y/Y)

CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (CRSP)